Saudi UDI Deadline Looms: Pure Global on Navigating Riyadh's Final Compliance Phase.

Failed to add items

Sorry, we are unable to add the item because your shopping basket is already at capacity.

Add to cart failed.

Please try again later

Add to wishlist failed.

Please try again later

Remove from wishlist failed.

Please try again later

Follow podcast failed

Unfollow podcast failed

Saudi UDI Deadline Looms: Pure Global on Navigating Riyadh's Final Compliance Phase.

Listen for free

View show details

About this listen

This week on MENA MedTech Insights, we dissect the Saudi Food and Drug Authority's (SFDA) final deadline for Unique Device Identification (UDI) compliance. With the clock ticking towards March 2026, we explore why this is more than just a labeling change and how it's poised to disrupt the entire medical device supply chain in the Kingdom. This isn't just a regulatory hurdle; it's a complex data management and logistics challenge that could determine who leads and who lags in one of the Middle East's most lucrative markets. We uncover the specific nuances of the SaudiDI database and why simply having a barcode isn't nearly enough to ensure market access. Consider this case: a leading European device manufacturer had its multi-million dollar shipment blocked at the Saudi border. They had the right barcode but had failed to complete a critical, yet poorly understood, data submission step. This single oversight led to months of delays, lost revenue, and a frantic scramble to avoid losing their market position to more prepared competitors. Key questions answered in this episode: - What are the precise UDI compliance deadlines for Class I, II, and III devices? - How does the SaudiDI database fundamentally differ from the FDA's GUDID or Europe's EUDAMED? - Why is your existing GS1 barcode insufficient for guaranteeing SFDA compliance? - What are the top three submission errors that lead to immediate rejection by the SFDA? - How can your UDI strategy for Saudi Arabia be leveraged for broader GCC market access? - What are the hidden data integration costs that can derail your compliance budget? - Are your local distributors in Riyadh and Jeddah prepared for these new import rules? - What specific technical documentation is now required for your MDMA renewal? Struggling to navigate the complexities of global MedTech regulations? Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies. We combine local expertise in over 30 markets, including Saudi Arabia, with advanced AI tools to streamline your market access. From developing your regulatory strategy to compiling and submitting your technical dossier, we ensure you stay compliant and competitive. Contact Pure Global for a consultation at info@pureglobal.com or visit us at https://pureglobal.com/.

No reviews yet